logo

For the Inventor, By the Inventor

Longjumeau, France

Nathalie Rakotoarisoa

This inventor holds 7 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignees: Sanofi, Sanofi-Aventis. Active years: 2007-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nathalie Rakotoarisoa. Retrieved from https://idiyas.com/inventor/nathalie-rakotoarisoa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Longiumeau, FR (2010)
  • Antony, FR (2012)
  • Longjumeau, FR (2007 - 2013)
  • Paris, FR (2012 - 2013)

Company Filing History:

goldMedal4 out of 1,553 
 
Sanofi
 patents
silverMedal3 out of 390 
 
Sanofi-Aventis
 patents

Years Active: 2007-2013

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents
1. 8598166 - Polysubstituted derivatives of 6-heteroarylimidazo[1,2-a]pyridines, and preparation and therapeutic use thereof (2013-12-03),
2. 8507520 - Polysubstituted 2-aryl-6-phenylimidazo[1,2-A]pyridine derivatives, and preparation and therapeutic use thereof (2013-08-13),
3. 8338451 - [object Object] (2012-12-25),
4. 8288376 - [object Object] (2012-10-16),
5. 8143248 - Tricyclic N-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use (2012-03-27),
6. 7700585 - Derivatives of N-[phenyl(pyrrolidine-2-YL)methyl]benzamide and N-[(azepan-2-YL) phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics (2010-04-20),
7. 7226917 - Derivatives of N-[phenyl(pyrrolidine-2-yl)methyl]benzamide and N-[(azepan-2-yl)phenylmethyl]benzamide, preparation, and use in treatment of schizophrenia (2007-06-05),

Title: Nathalie Rakotoarisoa: Pioneering Inventor in Pharmaceutical Innovations

Introduction:

Nathalie Rakotoarisoa's relentless drive for innovation has positioned her as a leading figure in the world of inventors and patent holders. Hailing from Longjumeau, FR, Nathalie's passion for pushing boundaries and creating novel solutions has earned her a reputation for groundbreaking work in the realm of pharmaceutical inventions.

Latest Patents:

Nathalie Rakotoarisoa has made significant strides in pharmaceutical innovations with her latest patents, including "Polysubstituted derivatives of 6-heteroarylimidazo[1,2-a]pyridines, and preparation and therapeutic use thereof" as well as "Polysubstituted 2-aryl-6-phenylimidazo[1,2-A]pyridine derivatives, and preparation and therapeutic use thereof." These patents underline her expertise in developing novel compounds and their therapeutic applications.

Career Highlights:

Throughout her career, Nathalie Rakotoarisoa has showcased her prowess in the pharmaceutical industry through her contributions at renowned companies like Sanofi and Sanofi-Aventis. Her innovative spirit and dedication to advancing healthcare solutions have led to the successful development of groundbreaking pharmaceutical compounds.

Collaborations:

Nathalie Rakotoarisoa has collaborated with esteemed professionals in the industry, including her coworkers Yannick Evanno and David Machnik. Together, they have synergized their expertise to drive forward innovative projects and shape the future of pharmaceutical inventions.

Conclusion:

Nathalie Rakotoarisoa's journey as an inventor exemplifies the transformative power of creativity and dedication in the realm of pharmaceutical innovations. Her patents and collaborations serve as testaments to her profound impact on the industry, inspiring future generations to pursue their inventive dreams and revolutionize healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…